期刊文献+

阿莫西林四联疗法致重症多形红斑药疹1例 被引量:5

Severe polymorphic erythematous eruption caused by amoxicillin quadruple therapy
下载PDF
导出
摘要 1例63岁老年女性患者,因确诊“幽门螺杆菌感染”首次服用阿莫西林胶囊、克拉霉素分散片、复方铝酸铋颗粒及兰索拉唑胶囊治疗,在门诊进行阿莫西林皮试,结果为阴性。服药3d后面部、眼睑明显肿胀,全身多处皮肤潮红,皮疹范围约占全身70%,可见少量水疱破裂,伴有高热,视物模糊。实验室检查血常规示:外周白细胞计数15.0×109·L-1,中性粒细胞计数92.31%,淋巴细胞百分率5.10%,C-反应蛋白166.28mg·L-1,诊断为“重症多形红斑药疹”。立即停止所有可疑药物,静脉滴注甲泼尼龙琥珀酸钠、人免疫球蛋白,并外用炉甘石洗剂于四肢及躯干,夫西地酸乳膏外用于面部。治疗3d后,患者体温恢复至正常,潮红肿胀明显消退,疼痛瘙痒消失,停用人免疫球蛋白,甲泼尼龙琥珀酸钠逐渐减量。后续皮疹情况持续改善,出院后口服醋酸泼尼松片。一周后复诊,皮疹全部消失。 A 63-year-old woman diagnosed as helicobacter pylori infection was first treated with amoxicillin capsules, clarithromycin dispersible tablets, compound bismuth aluminate granules and lansoprazole capsules. The skin test of amoxicillin was negative. After three days, her face and eyes were significantly swollen and many parts of the body were flushed. 70% of the body was covered by rashes and few blisters were broken. The patient also developed high fever and blurred vision. Results of laboratory examination showed that the count of blood white blood cells was 15.0 × 10^9·L^-1, the count ratio of neutrophils was 92.31%, the count ratio of lymphocytes was 5.10%, C-reactive protein was 166.28 mg·L^-1. The patient was diagnosed as severe drug eruption. All suspicious drugs were immediately stopped and successively treatment including intravenous drip of methylprednisolone sodium succinate and human immunoglobulin, external application of calamine lotion on the limbs and trunk and fusidic acid on the face. 3 days later, the flushing and swelling was significantly subsided and the body temperature returned to normal. And then human immunoglobulin was stopped and the dose of methylprednisolone sodium succinate was gradually reduced. The follow-up rash situation continued to improve and the patient was discharged with oral prednisone acetate tablets. A week later, the rash was wholly disappeared.
作者 孙文芳 王慧英 张晓兰 刘宪军 SUN Wen-fang;WANG Hui-ying;ZHANG Xiao-lan;LIU Xian-jun(Department of Pharmacy, Beijing Luhe Hospital, Capital Medical University, Beijing 101149, China)
出处 《中国药物应用与监测》 CAS 2019年第3期183-185,共3页 Chinese Journal of Drug Application and Monitoring
基金 北京市科技计划课题(Z181100001718144) 北京市通州区科技计划项目(KJ2018CX009) 通州区卫生发展科研专项项目任务书(TF-2017-PT-01-47)
关键词 阿莫西林 重症多形红斑药疹 药品不良反应 Amoxicillin Severe polymorphic erythematous eruption Adverse drug reaction
  • 相关文献

参考文献9

二级参考文献71

  • 1艾哈迈德,郑捷.药疹发病机理研究的几个热点[J].实用皮肤病学杂志,2009,2(3):149-152. 被引量:10
  • 2王彦,孙萱,周宇红,耿盈.几种常见大环内酯类抗生素的临床应用及不良反应[J].中国社区医师(医学专业),2005,7(23):13-13. 被引量:2
  • 3刘斌,王正春.药物不良反应258例报告分析[J].中国药师,2007,10(4):366-367. 被引量:44
  • 4温海波,郑锦坤,赖水招.179例药品不良反应报告分析与评价[J].首都医药,2007,14(05X):44-45. 被引量:9
  • 5Bastuji-Garin S, Rzany B, Stem RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme[J]. Arch Dermatol, 1993, 129(1): 92-96.
  • 6Schneck J, Fagot JP, Sekula P, et al. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study[J]. J Am Acad Dermatol, 2008, 58(1): 33-40.
  • 7Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions[J]. Clin Pharmacol Ther, 1981, 30(2): 239-245.
  • 8Sassolas B, Haddad C, Mockenhaupt M, et al. ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case- control analysis[J]. Clin Pharmacol Ther, 2010, 88(1): 60-68.
  • 9Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis[J]. N Engl J Med, 1995, 333(24): 1600-1607.
  • 10Mockenhaupt M, Viboud C, Dunant A, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marked drugs. The EuroSCAR-study[J]. J Invest Dermatol, 2008, 128(1): 35-44.

共引文献103

同被引文献31

引证文献5

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部